22 results on '"KLEBSIELLA pneumoniae"'
Search Results
2. Prevalence of carbapenem-resistant gram-negative bacteria among neonates suspected for sepsis in Africa: a systematic review and meta-analysis.
- Author
-
Sisay, Assefa, Asmare, Zelalem, Kumie, Getinet, Gashaw, Yalewayker, Getachew, Ermias, Ashagre, Agenagnew, Nigatie, Marye, Ayana, Sisay, Misganaw, Tadesse, Dejazmach, Zelalem, Abebe, Wagaw, Gedfie, Solomon, Tadesse, Selamyhun, Gashaw, Muluken, Jemal, Abdu, Kassahun, Woldeteklehymanot, Kidie, Atitegeb Abera, Abate, Biruk Beletew, Mulugeta, Chalie, and Alamrew, Abebaw
- Subjects
- *
CARBAPENEM-resistant bacteria , *GRAM-negative bacteria , *ESCHERICHIA coli , *NEONATAL sepsis , *ANTIMICROBIAL stewardship , *KLEBSIELLA pneumoniae - Abstract
Background: The emergence and rapid spread of gram-negative bacteria resistant to carbapenems among newborns is concerning on a global scale. Nonetheless, the pooled estimate of gram-negative bacteria resistant to carbapenem that cause neonatal sepsis in developing nations remains unknown. Thus, this study aimed to determine the combined prevalence of gram-negative bacteria resistant to carbapenem in African newborns who were suspected of having sepsis. Methods: All studies published from January 1, 2010, up to December 30, 2023, from PubMed, Science Direct, Scopus electronic databases, and the Google Scholar search engine were researched. Isolates tested for carbapenem from neonates with sepsis, English language papers conducted in Africa, and cross-sectional and cohort studies papers were included. Using PRISMA guidelines, we systematically reviewed and meta-analyzed studies that assessed the prevalence of carbapenem-resistant gram-negative bacteria. The "Joanna Briggs Institute" was used critically to evaluate the quality of the included studies. The data analysis was carried out using STATA™ version 17. Heterogeneity across the studies was evaluated using Q and I 2 tests. The subgroup analysis was done and, funnel plot and Egger's regression test were used to detect publication bias. A sensitivity analysis was conducted. Results: All 36 studies were included in the meta-analysis and systematic review. The pooled prevalence of carbapenem resistance in Africa was 30.34% (95% CI 22.03–38.64%). The pooled estimate of gram-negative bacteria resistant to imipenem, and meropenem was 35.57% (95% CI 0.67–70.54%) and 34.35% (95% CI 20.04% – 48.67%), respectively. A. baumannii and Pseudomonas spp. had pooled prevalence of 45.9% (95% CI 33.1–58.7%) and 43.0% (95% CI 23.0–62.4%), respectively. Similarly, Pseudomonas spp. and A. baumannii also exhibited strong meropenem resistance, with a pooled prevalence of 29.2% (95% CI 4.8–53.5%) and 36.7% (95% CI 20.1–53.3%), respectively. E. coli and K. pneumoniae were the two most common isolates. Conclusion: There should be urgent antimicrobial stewardship practices, strengthened surveillance systems and effective treatment for neonates with sepsis. There was remarkable variation in resistance across the continent. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Global prevalence of mutation in the mgrB gene among clinical isolates of colistin-resistant Klebsiella pneumoniae: a systematic review and meta-analysis.
- Author
-
Khoshbayan, Amin, Narimisa, Negar, Elahi, Zahra, Bostanghadiri, Narjess, Razavi, Shabnam, and Shariati, Aref
- Subjects
KLEBSIELLA pneumoniae ,GENETIC mutation ,MEDLINE ,COLISTIN ,SUBGROUP analysis (Experimental design) - Abstract
Background: Colistin is used as a last resort for managing infections caused by multidrug-resistant bacteria. However, the high emergence of colistin-resistant strains has restricted the clinical use of this antibiotic in the clinical setting. In the present study, we evaluated the global prevalence of the mutation in the mgrB gene, one of the most important mechanisms of colistin resistance in Klebsiella pneumoniae. Methods: Several databases, including Scopus, Medline (via PubMed), and Web of Science, were searched (until August 2023) to identify those studies that address the mgrB mutation in clinical isolates of K. pneumoniae. Using Stata software, the pooled prevalence of mgrB mutation and subgroup analyses for the year of publication, country, continent, mgrB mutation types, and detection methods of mgrB mutation were analyzed. Results: Out of the 115 studies included in the analysis, the prevalence of mgrB mutations in colistin-resistant K. pneumoniae isolates was estimated at 65% of isolates, and mgrB variations with insertional inactivation had the highest prevalence among the five investigated mutations with 69%. The year subgroup analysis indicated an increase in mutated mgrB from 46% in 2014 to 61% in 2022. Europe had the highest prevalence of mutated mgrB at 73%, while Africa had the lowest at 54%. Conclusion: Mutations in the mgrB gene are reported as one of the most common mechanisms of colistin resistance in K. pneumoniae, and the results of the present study showed that 65% of the reported colistin-resistant K. pneumoniae had a mutation in this gene. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. The Importance of Carbapenemase-Producing Enterobacterales in African Countries: Evolution and Current Burden.
- Author
-
Chelaru, Edgar-Costin, Muntean, Andrei-Alexandru, Hogea, Mihai-Octav, Muntean, Mădălina-Maria, Popa, Mircea-Ioan, and Popa, Gabriela-Loredana
- Subjects
KLEBSIELLA infections ,MEDICAL subject headings ,MULTIDRUG resistance ,KLEBSIELLA pneumoniae ,DRUG resistance in microorganisms ,COLONIZATION - Abstract
Antimicrobial resistance (AMR) is a worldwide healthcare problem. Multidrug-resistant organisms (MDROs) can spread quickly owing to their resistance mechanisms. Although colonized individuals are crucial for MDRO dissemination, colonizing microbes can lead to symptomatic infections in carriers. Carbapenemase-producing Enterobacterales (CPE) are among the most important MDROs involved in colonizations and infections with severe outcomes. This review aimed to track down the first reports of CPE in Africa, describe their dissemination throughout African countries and summarize the current status of CRE and CPE data, highlighting current knowledge and limitations of reported data. Two database queries were undertaken using Medical Subject Headings (MeSH), employing relevant keywords to identify articles that had as their topics beta-lactamases, carbapenemases and carbapenem resistance pertaining to Africa or African regions and countries. The first information on CPE could be traced back to the mid-2000s, but data for many African countries were established after 2015–2018. Information is presented chronologically for each country. Although no clear conclusions could be drawn for some countries, it was observed that CPE infections and colonizations are present in most African countries and that carbapenem-resistance levels are rising. The most common CPE involved are Klebsiella pneumoniae and Escherichia coli, and the most prevalent carbapenemases are NDM-type and OXA-48-type enzymes. Prophylactic measures, such as screening, are required to combat this phenomenon. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.
- Author
-
Aiken, Alexander M, Rehman, Andrea M, de Kraker, Marlieke E A, Madrid, Lola, Kebede, Meron, Labi, Appiah-Korang, Obeng-Nkrumah, Noah, Nyamwaya, Brian, Kagucia, Eunice, Cocker, Derek, Kawaza, Kondwani, Lester, Rebecca, Iregbu, Kenneth C, Medugu, Nubwa, Nwajiobi-Princewill, Philip I, Dramowski, Angela, Sonda, Tolbert, Hemed, Asia, Fwoloshi, Sombo, and Ojok, David
- Subjects
- *
KLEBSIELLA pneumoniae , *COHORT analysis , *THIRD generation cephalosporins , *HOSPITAL wards , *LONGITUDINAL method , *BLOOD collection , *KLEBSIELLA infections , *URINARY tract infections - Abstract
Bacteria of the order Enterobacterales are common pathogens causing bloodstream infections in sub-Saharan Africa and are frequently resistant to third-generation cephalosporin antibiotics. Although third-generation cephalosporin resistance is believed to lead to adverse outcomes, this relationship is difficult to quantify and has rarely been studied in this region. We aimed to measure the effects associated with resistance to third-generation cephalosporins in hospitalised patients with Enterobacterales bloodstream infection in Africa. We conducted a prospective, matched, parallel cohort study at eight hospitals across sub-Saharan Africa. We recruited consecutive patients of all age groups with laboratory-confirmed Enterobacterales bloodstream infection and matched them to at least one patient without bloodstream infection on the basis of age group, hospital ward, and admission date. Date of infection onset (and enrolment) was defined as the day of blood sample collection for culturing. Patients infected with bacteria with a cefotaxime minimum inhibitory concentration of 1 mg/L or lower were included in the third-generation cephalosporin-susceptible (3GC-S) cohort, and the remainder were included in the third-generation cephalosporin-resistant (3GC-R) cohort. The primary outcomes were in-hospital death and death within 30 days of enrolment. We used adjusted multivariable regression models to first compare patients with bloodstream infection against matched patients within the 3GC-S and 3GC-R cohorts, then compared estimates between cohorts. Between Nov 1, 2020, and Jan 31, 2022, we recruited 878 patients with Enterobacterales bloodstream infection (221 [25·2%] to the 3GC-S cohort and 657 [74·8%] to the 3GC-R cohort) and 1634 matched patients (420 [25·7%] and 1214 [74·3%], respectively). 502 (57·2%) bloodstream infections occurred in neonates and infants (age 0–364 days). Klebsiella pneumoniae (393 [44·8%] infections) and Escherichia coli (224 [25·5%] infections) were the most common Enterobacterales species identified. The proportion of patients who died in hospital was higher in patients with bloodstream infection than in matched controls in the 3GC-S cohort (62 [28·1%] of 221 vs 22 [5·2%] of 420; cause-specific hazard ratio 6·79 [95% CI 4·06–11·37] from Cox model) and the 3GC-R cohort (244 [37·1%] of 657 vs 115 [9·5%] of 1214; 5·01 [3·96–6·32]). The ratio of these cause-specific hazard ratios showed no significant difference in risk of in-hospital death in the 3GC-R cohort versus the 3GC-S cohort (0·74 [0·42–1·30]). The ratio of relative risk of death within 30 days (0·82 [95% CI 0·53–1·27]) also indicated no difference between the cohorts. Patients with bloodstream infections with Enterobacterales bacteria either resistant or susceptible to third-generation cephalosporins had increased mortality compared with uninfected matched patients, with no differential effect related to third-generation cephalosporin-resistance status. However, this finding does not account for time to appropriate antibiotic treatment, which remains clinically important to optimise. Measures to prevent transmission of Enterobacterales could reduce bloodstream infection-associated mortality from both drug-resistant and drug-susceptible bacterial strains in Africa. Bill & Melinda Gates Foundation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. PHYTOCHEMICAL AND ANTIMICROBIAL ACTIVITY OF CEIBA PENTANRA AGAINST SOME CLINICAL PATHOGENIC BACTERIA.
- Author
-
A., Banso and M. A., Ajayi
- Subjects
- *
KLEBSIELLA pneumoniae , *PATHOGENIC bacteria , *ANTI-infective agents , *ESCHERICHIA coli , *PLANT extracts , *ETHYL acetate , *ETHANOL , *PLANT metabolites - Abstract
Many of the plant materials used in traditional medicine are readily available in rural areas and thus have made traditional medicine relatively cheaper than modern medicine. Plants generally produce many secondary metabolites and these constitute an important source of microbiocides, pesticides and many pharmaceutical drugs. Ceiba pentandra is naturally present in equatorial Africa and naturalized in all the humid tropics including Nigeria. Ethyl acetate, ethanol and aqueous leave extract of Ceiba pentandra were assayed against clinical isolates of S. aureus, P.vulgaris, E. coli and K. pneumoniae by agar diffusion method. All the extracts showed antimicrobial activity against all the test organisms. K. pneumoniae was the most susceptible to the plant extracts while E. coli was the most resistant. The minimum inhibitory concentration of the plant extracts against the test organisms ranged between 15μg/mLto30μg/mL The minimum bactericidal concentration of the extracts was within the ranges of 15μg/mL and 35μg/mL Ethyl acetate extract of leaf of Ceiba pentandra appeared to be more effective than aqueous or ethanol extract as antimicrobial agent against all the test bacteria. The results obtained may suggest that the plant extracts possess useful antimicrobial properties. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Investigating the evolution and predicting the future outlook of antimicrobial resistance in sub-saharan Africa using phenotypic data for Klebsiella pneumoniae: a 12-year analysis.
- Author
-
Aruhomukama, Dickson and Nakabuye, Hellen
- Subjects
- *
DRUG resistance in microorganisms , *KLEBSIELLA pneumoniae , *CEFTAZIDIME , *MEROPENEM , *AZTREONAM , *CEFEPIME , *IMIPENEM - Abstract
Background: Antimicrobial resistance (AMR) is a major public health challenge, particularly in sub-Saharan Africa (SSA). This study aimed to investigate the evolution and predict the future outlook of AMR in SSA over a 12-year period. By analysing the trends and patterns of AMR, the study sought to enhance our understanding of this pressing issue in the region and provide valuable insights for effective interventions and control measures to mitigate the impact of AMR on public health in SSA. Results: The study found that general medicine patients had the highest proportion of samples with AMR. Different types of samples showed varying levels of AMR. Across the studied locations, the highest resistance was consistently observed against ceftaroline (ranging from 68 to 84%), while the lowest resistance was consistently observed against ceftazidime avibactam, imipenem, meropenem, and meropenem vaborbactam (ranging from 92 to 93%). Notably, the predictive analysis showed a significant increasing trend in resistance to amoxicillin-clavulanate, cefepime, ceftazidime, ceftaroline, imipenem, meropenem, piperacillin-tazobactam, and aztreonam over time. Conclusions: These findings suggest the need for coordinated efforts and interventions to control and prevent the spread of AMR in SSA. Targeted surveillance based on local resistance patterns, sample types, and patient populations is crucial for effective monitoring and control of AMR. The study also highlights the urgent need for action, including judicious use of antibiotics and the development of alternative treatment options to combat the growing problem of AMR in SSA. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Antibiotic-resistance in medically important bacteria isolated from commercial herbal medicines in Africa from 2000 to 2021: a systematic review and meta-analysis.
- Author
-
Walusansa, Abdul, Asiimwe, Savina, Nakavuma, Jesca. L., Ssenku, Jamilu. E., Katuura, Esther, Kafeero, Hussein. M., Aruhomukama, Dickson, Nabatanzi, Alice, Anywar, Godwin, Tugume, Arthur K., and Kakudidi, Esezah K.
- Subjects
- *
KLEBSIELLA pneumoniae , *HERBAL medicine , *BACTERIAL contamination , *DRUG resistance in bacteria , *DRUG resistance in microorganisms , *PATHOGENIC bacteria - Abstract
Background: Antimicrobial resistance is swiftly increasing all over the world. In Africa, it manifests more in pathogenic bacteria in form of antibiotic resistance (ABR). On this continent, bacterial contamination of commonly used herbal medicine (HM) is on the increase, but information about antimicrobial resistance in these contaminants is limited due to fragmented studies. Here, we analyzed research that characterized ABR in pathogenic bacteria isolated from HM in Africa since 2000; to generate a comprehensive understanding of the drug-resistant bacterial contamination burden in this region. Methods: The study was conducted according to standards of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). We searched for articles from 12 databases. These were: PubMed, Science Direct, Scifinder scholar, Google scholar, HerbMed, Medline, EMBASE, Cochrane Library, International Pharmaceutical Abstracts, Commonwealth Agricultural Bureau Abstracts, African Journal Online, and Biological Abstracts. Prevalence and ABR traits of bacterial isolates, Cochran's Q test, and the I2 statistic for heterogeneity were evaluated using MedCalcs software. A random-effects model was used to determine the pooled prevalence of ABR traits. The potential sources of heterogeneity were examined through sensitivity analysis, subgroup analysis, and meta-regression at a 95% level of significance. Findings: Eighteen studies met our inclusion criteria. The pooled prevalence of bacterial resistance to at least one conventional drug was 86.51% (95% CI = 61.247–99.357%). The studies were highly heterogeneous (I2 = 99.17%; p < 0.0001), with no evidence of publication bias. The most prevalent multidrug-resistant species was Escherichia coli (24.0%). The most highly resisted drug was Ceftazidime with a pooled prevalence of 95.10% (95% CI = 78.51–99.87%), while the drug-class was 3rd generation cephalosporins; 91.64% (95% CI = 78.64–96.73%). None of the eligible studies tested isolates for Carbapenem resistance. Extended Spectrum β-lactamase genes were detected in 89 (37.2%) isolates, mostly Salmonella spp., Proteus vulgaris, and K. pneumonia. Resistance plasmids were found in 6 (5.8%) isolates; the heaviest plasmid weighed 23,130 Kilobases, and Proteus vulgaris harbored the majority (n = 5; 83.3%). Conclusions: Herbal medicines in Africa harbor bacterial contaminants which are highly resistant to conventional medicines. This points to a potential treatment failure when these contaminants are involved in diseases causation. More research on this subject is recommended, to fill the evidence gaps and support the formation of collaborative quality control mechanisms for the herbal medicine industry in Africa. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Epidemiology of clinically suspected and laboratory-confirmed bloodstream infections at a South African neonatal unit.
- Author
-
Dramowski, Angela, Bekker, Adrie, Cotton, Mark Frederic, Whitelaw, Andrew Christopher, and Coffin, Susan
- Subjects
- *
LOW birth weight , *NEONATAL sepsis , *KLEBSIELLA pneumoniae , *DEATH rate , *NEONATAL infections - Abstract
Introduction: Data from Africa reporting the epidemiology of infection in hospitalised neonates are limited. Methodology: A prospective study with convenience sampling was conducted to characterise neonates investigated with blood culture/s for suspected infection at a 132-bed neonatal unit in Cape Town, South Africa (1 February-31 October 2018). Enrolled neonates were classified as having proven bloodstream infection (BSI) (blood culture-positive with a pathogen) or presumed infection (clinically suspected but blood culture-negative) or as potentially at risk of infection (maternal risk factors at birth). Results: Of 1299 hospitalised neonates with >1 blood culture sampling episode, 712 (55%) were enrolled: 126 (17.7%) had proven BSI; 299 (42%) had presumed infection and 287 (40.3%) were potentially at risk of infection. Neonates with proven BSI had lower birth weight and higher rates of co-existing surgical conditions versus the presumed/potential infection groups (p < 0.001). Median onset of proven BSI versus presumed infection was at 8 (IQR = 5-13) and 1 (IQR = 0-5) days respectively (p < 0.001). Most proven BSI were healthcare-associated (114/126; 90.5%), with Klebsiella pneumoniae (80.6% extended-spectrum ?-lactamase producers) and Staphylococcus aureus (66.7% methicillin-resistant) predominating. Mortality from proven BSI (34/126; 27%) was substantially higher than that observed in presumed (8/299; 2.7%) and potential infections (3/287; 1.0%) (p < 0.001). The odds of death from proven BSI was 3-fold higher for Gram-negatives than for Gram-positive/fungal pathogens (OR = 3.23; 95% CI = 1.17-8.92). Conclusions: Proven BSI episodes were predominantly healthcare-associated and associated with a high case fatality rate. Most neonates with presumed infection or at potential risk of infection had favourable 30-day outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Healthcare-associated outbreaks of bacterial infections in Africa, 2009–2018: A review.
- Author
-
Fraser, Jessica L., Mwatondo, Athman, Alimi, Yewande H., Varma, Jay K., and Vilas, Victor J. Del Rio
- Subjects
- *
BACTERIAL diseases , *DISEASE relapse , *KLEBSIELLA pneumoniae , *WORLD health , *PUBLIC health - Abstract
• Healthcare-associated bacterial infections are a major global public health issue. • Failure to report outbreaks can increase the risk of recurrent outbreaks. • Few centres in Africa have reported outbreaks, suggesting under-detection and under-reporting. • Interventions to control outbreaks have recommended enhancing hand hygiene and education. • Quality of reporting requires improvement to ensure changes in practices. Healthcare-associated infections (HAIs) are a major global public health problem, increasing the transmission of drug-resistant infections. In Africa, the prevalence of HAIs among all hospital inpatients is estimated to be between 3% and 15%, but outbreaks are infrequently reported. Failure to detect and/or report outbreaks can increase the risk of ongoing infections and recurrent outbreaks. A search of the PubMed, Web of Science, Cochrane Library, and other outbreak databases was performed to identify published literature on bacterial HAI outbreaks in Africa (January 2009 to December 2018). Details of the outbreak characteristics, hospital environment, and the control measures implemented were extracted. Twenty-two studies published over the 10-year period were identified. These reported 31 distinct outbreaks and a total of 31 causative pathogens, including Klebsiella pneumoniae (six outbreaks, 19%), Staphylococcus aureus (six outbreaks, 19%), and Enterococcus (five outbreaks, 16%). Most outbreaks were reported from university (n = 8, 26%) and tertiary hospitals (n = 11, 55%), from South Africa (n = 9, 41%) and Tunisia (n = 4, 18%). Interventions to control the outbreaks were described in 27 (90%) outbreaks, and all instituted or recommended enhancing hand hygiene and education. Few facilities in Africa reported HAI outbreaks over the 10-year period, suggesting substantial under-detection and under-reporting. The quality and timeliness of reporting require improvement to ensure changes in public health practice. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Extracts of Gomphrena celosioides Mart as potential treatment for urinary tract infections against antibiotic resistant β-lactamase producing uropathogens.
- Author
-
Omokhua-Uyi, Aitebiremen Gift and Van Staden, Johannes
- Subjects
- *
FOSFOMYCIN , *URINARY tract infections , *GENTIAN violet , *EXTRACTS , *HOT water , *KLEBSIELLA pneumoniae - Abstract
• Extracts of different parts of Gomphrena celosioides showed promising antibacterial activity against selected β-lactamase producing uropathogens. • Extracts from Gomphrena celosioides exhibited concentration and time-dependent patterns of antibacterial activity. • Hot water extracts from Gomphrena celosioides exhibited potent anti-biofilm activity. • All extracts tested showed a relatively safe margin in the cytotoxicity assay, indicating that pharmacological activity displayed was not as a result of toxicity. Gomphrena celosioides Mart is used traditionally for the treatment of urinary tract infections (UTIs) and related diseases in Asia and Africa. The study evaluated the antibacterial and anti-biofilm potentials of G. celosioides against β-lactamase producing Escherichia coli, Klebsiella pneumoniae , and Staphylococcus aureus. The leaves, twigs, flowers and a combination of all plant parts of G. celosioides were extracted with hot water and acetone. Antibacterial activity was investigated through spectrophotometric and p -iodonitrotetrazolium chloride colorimetric methods. The crystal violet staining method was employed to determine the biofilm inhibition ability of the extracts. Safety levels of the extracts was evaluated against Vero monkey kidney cells through the MTT colorimetric assay. No antibacterial activity was displayed by any of the water extracts against tested organisms. However, all acetone extracts showed good antibacterial activity with minimum inhibitory concentrations (MICs) from 0.04 to 0.31 mg/mL. This corresponded to minimum percentage bacteriostatic activity ranging from 50.5 to 90%, showing a dose dependent pattern. All extracts including the water extracts, which did not show any sign of antibacterial activity at the highest concentration tested, showed promising anti-biofilm activity above 50% against all strains at the planktonic and biofilm formation stages. However, activity exhibited by the acetone extracts against E. coli at 0 and 24 h was weak. The tested MICs of acetone extracts including ciprofloxacin in the proliferation assay were more active against the organisms at 24 h except for S. aureus where all samples were more active at 18 h. A selectivity index between 0.61 and 4.75 showed that the extracts are relatively safe. Following the promising biological activity observed in this study, future studies such as identification of active constituents, mechanisms of action and in vivo evaluations are required. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Do vegetarians less frequently carry ESBL/pAmpC-producing Escherichia coli/Klebsiella pneumoniae compared with non-vegetarians?
- Author
-
Meijs, Anouk P, Gijsbers, Esther F, Hengeveld, Paul D, Veenman, Christiaan, Roon, Annika M van, Hoek, Angela H A M van, Greeff, Sabine C de, Duijkeren, Engeline van, Dierikx, Cindy M, van Roon, Annika M, van Hoek, Angela H A M, de Greeff, Sabine C, and van Duijkeren, Engeline
- Subjects
- *
VEGETARIAN foods , *KLEBSIELLA pneumoniae , *ESCHERICHIA coli , *ENTEROBACTERIACEAE , *VEGETARIANS , *HAND washing , *MEAT , *KLEBSIELLA , *BACTERIAL proteins , *RESEARCH , *SEQUENCE analysis , *ANIMAL experimentation , *RESEARCH methodology , *MEDICAL cooperation , *EVALUATION research , *HYDROLASES , *COMPARATIVE studies , *ESCHERICHIA coli diseases , *GENES , *ANTIBIOTICS - Abstract
Background: ESBL and plasmid-mediated AmpC (pAmpC)-producing Enterobacteriaceae are frequently found on meat products in Dutch retail, especially on poultry.Objectives: We investigated whether vegetarians are at lower risk of carrying ESBL/pAmpC-producing Escherichia coli/Klebsiella pneumoniae (ESBL-E/K) compared with persons who consume meat.Methods: Vegetarians, pescatarians (vegetarians who eat fish) and non-vegetarians (persons who eat meat at least three times per week) were asked to send in a faecal sample and a questionnaire. ESBL-E/K were cultured and MLSTs were determined. ESBL/pAmpC genes were analysed using PCR and sequencing. The risk of ESBL-E/K carriage in the three study groups was analysed using multivariable logistic regression.Results: Prevalence of ESBL-E/K carriage was 8.0% in vegetarians (63/785; 95% CI 6.3-10.1), 6.9% in pescatarians (27/392; 95% CI 4.8-9.8) and 3.8% in non-vegetarians (14/365; 95% CI 2.3-6.3). Multivariable analysis showed an OR for ESBL-E/K carriage of 2.2 for vegetarians (95% CI 1.2-4.0) and 1.6 for pescatarians (95% CI 0.8-3.2) compared with non-vegetarians. The predominant MLST was E. coli ST131 and the most common ESBL genes were blaCTX-M-15, blaCTX-M-27, blaCTX-M-14 and blaCTX-M-1 in all diet groups. Independent risk factors for ESBL-E/K carriage were travel to Africa/Latin America/Asia (OR 4.6; 95% CI 2.8-7.7) in the past 6 months and rarely/never washing hands before food preparation (OR 2.5; 95% CI 1.2-5.0).Conclusions: Vegetarians and pescatarians did not have a lower risk of ESBL-E/K carriage compared with non-vegetarians, indicating that eating meat is not an important risk factor for ESBL-E/K carriage. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
13. Biofilm formation of hypermucoviscous and non-hypermucoviscous Klebsiella pneumoniae recovered from clinically affected African green monkey (Chlorocebus aethiops sabaeus).
- Author
-
Soto, Esteban, Dennis, Michelle M., Beierschmitt, Amy, Francis, Stewart, Sithole, Fortune, Halliday-Simmons, Iona, and Palmour, Roberta
- Subjects
- *
BIOFILMS , *KLEBSIELLA pneumoniae , *PHENOTYPES , *CERCOPITHECUS aethiops , *VETERINARY epidemiology , *PHYSIOLOGY , *DIAGNOSIS - Abstract
In recent years, an emergent Klebsiella pneumoniae hypermucoviscous (HMV) phenotype has been associated with increased invasiveness and pathogenicity in primates. The HMV phenotype is characterized by different capsular serotypes, associated with several genes including the rmpA (regulator of mucoid phenotype) and magA (mucoviscosity-associated) genes. In African green monkeys (AGM) ( Chlorocebus aethiops sabaeus ) serotypes K1 and K5 have been implicated in fatal multisystemic abscesses. In order to better understand the epizootiology of this pathogen, the capacity of biofilm production of K. pneumoniae isolates presenting the HMV was compared to non-HMV isolates at three different temperatures (25, 30 and 37 °C). The results indicate that HMV and non-HMV isolates display similar capacity to form biofilms at the three different evaluated temperatures. Temperature appears to play a role in the formation of biofilms by K. pneumoniae presenting the HMV phenotype, where larger biofilms were formed at 37 °C than at 25 °C. Knowledge regarding local environmental sources of K. pneumoniae and the possible role of wildlife in the maintenance of this agent in the area is necessary to develop effective recommendations for the prevention and management of this disease in captive AGM populations. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
14. Reports from Kafrelsheikh University Advance Knowledge in Gram-Negative Bacteria (A Novel Single-tube Eicosaplex/octaplex Pcr System for the Detection of Extended-spectrum Beta-lactamases, Plasmid-mediated Ampc Beta-lactamases, and Integrons In ...).
- Subjects
GRAM-negative bacteria ,INTEGRONS ,GRAM-negative bacterial diseases ,KLEBSIELLA pneumoniae - Abstract
Kafr El-Shaikh, Egypt, Africa, Amidohydrolases, Beta-Lactamases, Enzymes and Coenzymes, Gram-Negative Bacteria, Gram-Negative Bacterial Infections According to the news reporters, the research concluded: "We showed the prevalence of ESBLs and AmpC beta-lactamases among our panel of ampicillin-resistant Gram-negative strains and detection of NDM and OXA carbapenemases." Keywords: Kafr El-Shaikh; Egypt; Africa; Amidohydrolases; Beta-Lactamases; Enzymes and Coenzymes; Gram-Negative Bacteria; Gram-Negative Bacterial Infections EN Kafr El-Shaikh Egypt Africa Amidohydrolases Beta-Lactamases Enzymes and Coenzymes Gram-Negative Bacteria Gram-Negative Bacterial Infections 2023 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Data detailed on Gram-Negative Bacteria have been presented. [Extracted from the article]
- Published
- 2023
15. Epidemiology of Coxiella burnetii Infection in Africa: A OneHealth Systematic Review.
- Author
-
Vanderburg, Sky, Rubach, Matthew P., Halliday, Jo E. B., Cleaveland, Sarah, Reddy, Elizabeth A., and Crump, John A.
- Subjects
- *
Q fever , *COXIELLA burnetii , *KLEBSIELLA pneumoniae , *SCHMALLENBERG virus , *PARTURITION , *AFRICAN animals , *RESOURCE-limited settings , *DISEASE incidence - Abstract
Background: Q fever is a common cause of febrile illness and community-acquired pneumonia in resource-limited settings. Coxiella burnetii, the causative pathogen, is transmitted among varied host species, but the epidemiology of the organism in Africa is poorly understood. We conducted a systematic review of C. burnetii epidemiology in Africa from a "One Health" perspective to synthesize the published data and identify knowledge gaps. Methods/Principal Findings: We searched nine databases to identify articles relevant to four key aspects of C. burnetii epidemiology in human and animal populations in Africa: infection prevalence; disease incidence; transmission risk factors; and infection control efforts. We identified 929 unique articles, 100 of which remained after full-text review. Of these, 41 articles describing 51 studies qualified for data extraction. Animal seroprevalence studies revealed infection by C. burnetii (≤13%) among cattle except for studies in Western and Middle Africa (18–55%). Small ruminant seroprevalence ranged from 11–33%. Human seroprevalence was <8% with the exception of studies among children and in Egypt (10–32%). Close contact with camels and rural residence were associated with increased seropositivity among humans. C. burnetii infection has been associated with livestock abortion. In human cohort studies, Q fever accounted for 2–9% of febrile illness hospitalizations and 1–3% of infective endocarditis cases. We found no studies of disease incidence estimates or disease control efforts. Conclusions/Significance: C. burnetii infection is detected in humans and in a wide range of animal species across Africa, but seroprevalence varies widely by species and location. Risk factors underlying this variability are poorly understood as is the role of C. burnetii in livestock abortion. Q fever consistently accounts for a notable proportion of undifferentiated human febrile illness and infective endocarditis in cohort studies, but incidence estimates are lacking. C. burnetii presents a real yet underappreciated threat to human and animal health throughout Africa. Author Summary: Coxiella burnetii is a bacterium that can cause acute and chronic fever illness and pneumonia in humans. It is also a known cause of abortion in livestock species, and is principally transmitted to humans through contact with infected animal birth products. With growing awareness of the over-diagnosis and misclassification of malaria as the cause of fever illnesses in the tropics, including Africa, there is increased interest in the role of non-malarial causes of fever, such as C. burnetii. We performed a systematic review of the published literature on the epidemiology of C. burnetii in Africa to consolidate knowledge and identify knowledge gaps regarding the extent of this infection in humans and animals and the risk factors for infection transmission. Few studies on prevalence of infection in humans and animals used random sampling strategies, and among these only two studied linked human and animal populations. C. burnetii appears to be a common cause of severe fever illness in humans, but population-level incidence estimates are lacking. The differential risks for C. burnetii infection and potential control strategies within the various animal husbandry systems in Africa remain largely unexplored. We conclude that C. burnetii is an underappreciated threat to human and animal health throughout Africa. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
16. Novel strains of Klebsiella africana and Klebsiella pneumoniae in Australian fruit bats (Pteropus poliocephalus).
- Author
-
McDougall, Fiona K., Wyres, Kelly L., Judd, Louise M., Boardman, Wayne S.J., Holt, Kathryn E., and Power, Michelle L.
- Subjects
- *
KLEBSIELLA pneumoniae , *KLEBSIELLA , *KLEBSIELLA infections , *BATS , *FRUIT , *DRUG resistance in microorganisms - Abstract
Over the past decade human associated multidrug resistant (MDR) and hypervirulent Klebsiella pneumoniae lineages have been increasingly detected in wildlife. This study investigated the occurrence of K. pneumoniae species complex (KpSC) in grey-headed flying foxes (GHFF), an Australian fruit bat. Thirty-nine KpSC isolates were cultured from 275 GHFF faecal samples (14.2%), comprising K. pneumoniae (n = 30), Klebsiella africana (n = 8) and Klebsiella variicola subsp. variicola (n = 1). The majority (79.5%) of isolates belonged to novel sequence types (ST), including two novel K. africana STs. This is the first report of K. africana outside of Africa and in a non-human host. A minority (15.4%) of GHFF KpSC isolates shared STs with human clinical K. pneumoniae strains, of which, none belonged to MDR clonal lineages that cause frequent nosocomial outbreaks, and no isolates were characterised as hypervirulent. The occurrence of KpSC isolates carrying acquired antimicrobial resistance genes in GHFF was low (1.1%), with three K. pneumoniae isolates harbouring both fluoroquinolone and trimethoprim resistance genes. This study indicates that GHFF are not reservoirs for MDR and hypervirulent KpSC strains, but they do carry novel K. africana lineages. Health risks associated with KpSC carriage by GHFF are deemed low for the public and GHFF. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. Biological Activities and Composition of Salvia muirii L. Bol. Essential Oil.
- Author
-
Kamatou, Guy P. P., van Zyl, Robyn L., van Vuuren, Sandy F., Viljoen, Alvaro M., Figueiredo, A. Cristina, Barroso, José G., and Pedro, Luis G.
- Subjects
- *
ESSENTIAL oils , *MONOTERPENES , *SALVIA , *KLEBSIELLA pneumoniae , *BACILLUS cereus , *EPITHELIAL cells - Abstract
The essential oil of Salvia muirii L. Bol., a species indigenous to southern Africa was obtained by hydrodistillation (0.5%, v/f.w.) from the aerial parts and analyzed by GC and GC/MS. Thirty-nine components representing 98% of the oil were identified. The oil was dominated by monoterpene hydrocarbons (53%) and oxygen-containing monoterpenes (36%) with 1,8-cineole (23%), α-pinene (22%) and limonene (12%) being the major components. The oil exhibited potent antimalarial (IC50: 6μg/mL) and antibacterial activity especially against Klebsiella pneumoniae and Bacillus cereus with MIC values of 6 and 9mg/mL, respectively. The oil exhibited poor anti-inflammatory and antioxidant activity. The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide toxicity assay revealed that the essential oil of S. muirii should be used with caution as it displayed some degree of toxicity against the transformed human kidney epithelial cells (IC50: 3μg/mL). [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
18. A Bibliometric Meta-Analysis of Colistin Resistance in Klebsiella pneumoniae.
- Author
-
Nwabor, Ozioma Forstinus, Terbtothakun, Pawarisa, Voravuthikunchai, Supayang P., and Chusri, Sarunyou
- Subjects
COLISTIN ,KLEBSIELLA pneumoniae ,CARBAPENEM-resistant bacteria ,BIBLIOMETRICS ,PUBLISHED articles ,ANTIBIOTICS - Abstract
Colistin is a last resort antibiotic medication for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae. In recent years, various mechanisms have been reported to mediate colistin resistance in K. pneumoniae. This study reports a bibliometric analysis of published articles retrieved from the Scopus database relating to colistin resistance in K. pneumoniae. The research trends in colistin resistance and mechanisms of resistance were considered. A total of 1819 research articles published between 1995 and 2019 were retrieved, and the results indicated that 50.19% of the documents were published within 2017–2019. The USA had the highest participation with 340 (14.31%) articles and 14087 (17.61%) citations. Classification based on the WHO global epidemiological regions showed that the European Region contributed 42% of the articles while the American Region contributed 21%. The result further indicated that 45 countries had published at least 10 documents with strong international collaborations amounting to 272 links and a total linkage strength of 735. A total of 2282 keywords were retrieved; however, 57 keywords had ≥15 occurrences with 764 links and a total linkage strength of 2388. Furthermore, mcr-1, colistin resistance, NDM, mgrB, ceftazidime-avibactam, MDR, combination therapy, and carbapenem-resistant Enterobacteriaceae were the trending keywords. Concerning funders, the USA National Institute of Health funded 9.1% of the total research articles, topping the list. The analysis indicated poor research output, collaboration, and funding from Africa and South-East Asia and demands for improvement in international research collaboration. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. High Carriage Rates of Multidrug-Resistant Gram-Negative Bacteria in Neonatal Intensive Care Units From Ghana.
- Author
-
Labi, Appiah-Korang, Bjerrum, Stephanie, Enweronu-Laryea, Christabel C, Ayibor, Prosper K, Nielsen, Karen L, Marvig, Rasmus L, Newman, Mercy J, Andersen, Leif P, and Kurtzhals, Jorgen A L
- Subjects
- *
INTENSIVE care units , *NEONATAL intensive care , *GRAM-negative bacteria , *KLEBSIELLA pneumoniae , *SINGLE nucleotide polymorphisms , *NEONATAL infections - Abstract
Background Carriage of multidrug resistant (MDR) Gram-negative bacteria (GN) in hospitalized neonates may increase the risk of difficult-to-treat invasive infections at neonatal intensive care units (NICUs). Data on MDRGN carriage among hospitalized newborns in Africa are limited. Methods We conducted a cross-sectional study at the NICUs of 2 tertiary hospitals in Ghana. Swabs from the axilla, groin, perianal region, and the environment were cultured, GN were identified, and antibiotic susceptibility was tested. We obtained blood culture isolates from neonates with sepsis. Whole-genome sequencing was used to characterize carbapenemase-producing Klebsiella pneumoniae. Typing was done by multilocus sequence typing (MLST) and single nucleotide polymorphism (SNP) analysis. Results A total of 276 GN were isolated from 228 screened neonates. Pathogenic GN were cultured in 76.8% (175 of 228) of neonates. Klebsiella spp (41.7%; 115 of 276) and Escherichia coli (26.4%; 73 of 276) were the commonest organisms. Carriage rates of MDRGN and third-generation cephalosporin resistant organisms were 49.6% (113 of 228) and 46.1% (105 of 228), respectively. Among Klebsiella spp, 75.6% (87 of 115) phenotypically expressed extended-spectrum β-lactamase activity, whereas 15.6% expressed carbapenemase and harbored bla- OXA-181 and bla- CTX-M-15. Overall, 7.0% (16 of 228) of neonates developed GN bloodstream infection. In 2 of 11 neonates, sequencing showed the same identity between carriage and the bloodstream isolate. Length of stay before specimen collection and antibiotic use were independently associated with carriage rates, which increased from 13% at admission to 42% by day 2 and reached a plateau at 91% by day 15. Conclusions High carriage rates of MDRGN, including carbapenemase-producing enterobacterales may be an emerging problem in NICUs in Africa. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
20. In vitro activity of aztreonam/avibactam against a global collection of Klebsiella pneumoniae collected from defined culture sources in 2016 and 2017.
- Author
-
Esposito S, Stone GG, and Papaparaskevas J
- Subjects
- Africa, Anti-Bacterial Agents pharmacology, Asia, Azabicyclo Compounds, Europe, Latin America, Middle East, Aztreonam pharmacology, Klebsiella pneumoniae
- Abstract
Objectives: This study reports on the activity of aztreonam/avibactam (ATM-AVI) against a collection of Klebsiella pneumoniae collected in 2016 and 2017., Methods: Non-duplicate K. pneumoniae isolates were collected from four regions (Africa/Middle East, n = 785; Asia-Pacific, n = 1433; Europe, n = 4236; Latin America, n = 1499) and five culture sources (blood, n = 902; intra-abdominal, n = 992; urinary tract, n = 2148; skin and skin structure, n = 1409; lower respiratory tract, n = 2502). MICs were determined at a central laboratory using Clinical and Laboratory Standards Institute (CLSI) broth microdilution methodology. Susceptibility was determined using European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints., Results: For all culture sources, against all K. pneumoniae, the highest rates of susceptibility were seen for amikacin (>84%), ceftazidime/avibactam (>94%), colistin (>92%) and meropenem (>83%), and >99.9% of isolates were inhibited at an ATM-AVI MIC of ≤4 mg/L. Among meropenem-resistant (MEM-R, n = 583) and meropenem-resistant metallo-β-lactamase-negative (MEM-R-MBLN; n = 469) isolates, susceptibility was highest to ceftazidime/avibactam (79.9% and 99.4%, respectively) and colistin (67.2% and 62.7%, respectively). All MEM-R-MBLN isolates from blood, intra-abdominal, urinary tract and skin and skin structure sources, and all but one isolate from respiratory sources, were inhibited at an ATM-AVI MIC of ≤2 mg/L. Against the meropenem-resistant metallo-β-lactamase positive (MEM-R-MBLP; n = 114) isolates, susceptibility to colistin was between 75.0% (urinary tract isolates) and 93.3% (lower respiratory tract isolates). All MEM-R-MBLP isolates were inhibited at an ATM-AVI MIC of ≤0.5 mg/L., Conclusions: ATM-AVI is active against K. pneumoniae isolates from a range of culture sources across Africa/Middle East, Asia-Pacific, Europe and Latin America. ATM-AVI also has activity against MEM-R-MBLN and MEM-R-MBLP isolates., (Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
21. First report of NDM-1-producing Klebsiella pneumoniae imported from Africa to Italy: Evidence of the need for continuous surveillance.
- Author
-
Principe L, Mauri C, Conte V, Pini B, Giani T, Rossolini GM, and Luzzaro F
- Subjects
- Africa epidemiology, Anti-Bacterial Agents pharmacology, Bacterial Proteins genetics, Bacterial Proteins metabolism, Child, Preschool, Colistin pharmacology, Drug Resistance, Multiple, Bacterial genetics, Egypt, Enterobacteriaceae drug effects, Enterobacteriaceae enzymology, Enterobacteriaceae genetics, Genotype, Humans, Italy, Klebsiella Infections drug therapy, Klebsiella Infections transmission, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae genetics, Klebsiella pneumoniae isolation & purification, Klebsiella pneumoniae pathogenicity, Longitudinal Studies, Male, Microbial Sensitivity Tests, Middle Aged, Molecular Typing, Multilocus Sequence Typing, Surgical Wound microbiology, Tigecycline pharmacology, beta-Lactamases genetics, Klebsiella Infections epidemiology, Klebsiella Infections microbiology, Klebsiella pneumoniae enzymology, beta-Lactamases metabolism
- Abstract
Objectives: NDM-producing Enterobacteriaceae are considered emergent on the African continent and have been increasingly reported in recent years. In contrast, strains producing NDM-type enzymes have been rarely reported in Italy, usually associated with sporadic cases or small outbreaks. Here we report two cases of infection caused by NDM-1-producing Klebsiella pneumoniae (NDM-KP) in two unrelated patients returned from travel to Egypt., Case Reports: The two patients had been previously hospitalised for a short period in two different Egyptian hospitals. In our institution in Italy, NDM-KP isolates were detected from surgical wound drainage (patient #1) and respiratory secretions and blood cultures (patient #2). Rectal swabs of both patients were persistently positive for NDM-KP. In both cases, NDM-1-producing isolates exhibited a multidrug-resistant phenotype, being susceptible only to tigecycline and colistin. Analysis by multilocus sequence typing (MLST) revealed that the two K. pneumoniae isolates were not clonally related, belonging to different sequence types (STs), namely ST15 from patient #1 and ST11 from patient #2., Conclusions: To the best of our knowledge, this is the first report of NDM-producing isolates imported from Africa to Italy, with no obvious link to the Indian subcontinent. Our experience confirms that Egypt is an emergent source of NDM-producing Enterobacteriaceae, thus representing a cause of concern for Mediterranean countries. Owing to its geographical position, Italy is a first-line European checkpoint with respect to African countries and plays a pivotal role in limiting the dissemination of high-risk clones, especially considering the latest strong migration flows., (Copyright © 2016 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
22. Epidemiological status of extended spectrum betalactamase producing Klebsiella pneumoniae in sub-Saharian Africa (Mali) in international adoption.
- Author
-
Boisrame-Gastrin S, Chaffanel F, Münck MR, Gouriou S, and Tandé D
- Subjects
- Africa, Humans, Mali, beta-Lactamases, Klebsiella Infections, Klebsiella pneumoniae
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.